CY2183B1 - Antiprotozoal cyclic tetrapeptides - Google Patents
Antiprotozoal cyclic tetrapeptidesInfo
- Publication number
- CY2183B1 CY2183B1 CY0000043A CY0000043A CY2183B1 CY 2183 B1 CY2183 B1 CY 2183B1 CY 0000043 A CY0000043 A CY 0000043A CY 0000043 A CY0000043 A CY 0000043A CY 2183 B1 CY2183 B1 CY 2183B1
- Authority
- CY
- Cyprus
- Prior art keywords
- antiprotozoal
- cyclic tetrapeptides
- tetrapeptides
- cyclic
- coccidiosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
- C07K5/126—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/145—Fungi isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/77—Fusarium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28132594A | 1994-07-27 | 1994-07-27 | |
| US08/447,664 US5620953A (en) | 1994-07-27 | 1995-05-23 | Antiprotozoal cyclic tetrapeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY2183B1 true CY2183B1 (en) | 2002-08-23 |
Family
ID=26960833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY0000043A CY2183B1 (en) | 1994-07-27 | 2000-08-23 | Antiprotozoal cyclic tetrapeptides |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5620953A (de) |
| EP (1) | EP0777683B1 (de) |
| JP (1) | JPH10503368A (de) |
| AT (1) | ATE189460T1 (de) |
| AU (1) | AU687602B2 (de) |
| CA (1) | CA2194999A1 (de) |
| CY (1) | CY2183B1 (de) |
| DE (1) | DE69514928T2 (de) |
| WO (1) | WO1996003428A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5620953A (en) * | 1994-07-27 | 1997-04-15 | Merck & Co., Inc. | Antiprotozoal cyclic tetrapeptides |
| US6110697A (en) * | 1995-09-20 | 2000-08-29 | Merck & Co., Inc. | Histone deacetylase as target for antiprotozoal agents |
| US5922837A (en) * | 1995-09-20 | 1999-07-13 | Merck & Co., Inc. | Antiprotozoal cyclic tetrapeptides |
| GB9903087D0 (en) * | 1999-02-12 | 1999-03-31 | Glaxo Group Ltd | Process |
| WO2001007042A1 (en) * | 1999-07-23 | 2001-02-01 | Merck & Co., Inc. | Apicidin-derived cyclic tetrapeptides |
| US7018642B2 (en) * | 2001-04-27 | 2006-03-28 | The Procter & Gamble Company | Compounds, compositions, and methods for controlling biofilms |
| EP3461488A1 (de) | 2017-09-27 | 2019-04-03 | Onxeo | Kombination aus einem dbait-molekül und einem hdac-inhibitor zur behandlung von krebs |
| EP3461480A1 (de) | 2017-09-27 | 2019-04-03 | Onxeo | Kombination von checkpoint-hemmern des dna-schädigungsantwort-zellzyklus und belinostat zur behandlung von krebs |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2410658A1 (fr) * | 1977-11-30 | 1979-06-29 | Science Union & Cie | Nouveau produit biologique d'origine fongique, son obtention et son application a la therapeutique |
| US4338303A (en) * | 1980-02-04 | 1982-07-06 | Albert Einstein College Of Medicine Of Yeshiva University | Treatment of parasitic diseases |
| FR2503182A1 (fr) * | 1981-04-07 | 1982-10-08 | Biofarma Sa | Nouvelle souche de fusarium utilisable pour la production d'antibiotiques |
| JPH0334991A (ja) * | 1989-06-30 | 1991-02-14 | Shionogi & Co Ltd | 環状テトラペプチドおよびその製造法 |
| CA2032559C (en) * | 1989-12-28 | 2001-11-06 | Kiyofumi Ishikawa | Endothelin antagonistic cyclic pentapeptides |
| US5049546A (en) * | 1990-03-19 | 1991-09-17 | Merck & Co., Inc. | Antibiotic agents |
| US5369093A (en) * | 1991-03-15 | 1994-11-29 | Merck & Co., Inc. | Lipopeptide derivatives |
| EP0537418B1 (de) * | 1991-07-01 | 1998-05-13 | Ahc Inc. | Bacillus Bakterium und dessen Verwendung |
| US5300491A (en) * | 1991-10-31 | 1994-04-05 | Apothekernes Laboratorium A.S. | Treatment of protozoal infection |
| US5620953A (en) * | 1994-07-27 | 1997-04-15 | Merck & Co., Inc. | Antiprotozoal cyclic tetrapeptides |
-
1995
- 1995-05-23 US US08/447,664 patent/US5620953A/en not_active Expired - Fee Related
- 1995-07-24 JP JP8505930A patent/JPH10503368A/ja not_active Withdrawn
- 1995-07-24 CA CA002194999A patent/CA2194999A1/en not_active Abandoned
- 1995-07-24 DE DE69514928T patent/DE69514928T2/de not_active Expired - Fee Related
- 1995-07-24 EP EP95928135A patent/EP0777683B1/de not_active Expired - Lifetime
- 1995-07-24 WO PCT/US1995/009371 patent/WO1996003428A1/en not_active Ceased
- 1995-07-24 AT AT95928135T patent/ATE189460T1/de not_active IP Right Cessation
- 1995-07-24 AU AU32004/95A patent/AU687602B2/en not_active Ceased
-
1997
- 1997-01-28 US US08/789,931 patent/US5861375A/en not_active Expired - Fee Related
-
2000
- 2000-08-23 CY CY0000043A patent/CY2183B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH10503368A (ja) | 1998-03-31 |
| EP0777683B1 (de) | 2000-02-02 |
| ATE189460T1 (de) | 2000-02-15 |
| US5620953A (en) | 1997-04-15 |
| DE69514928D1 (de) | 2000-03-09 |
| WO1996003428A1 (en) | 1996-02-08 |
| DE69514928T2 (de) | 2000-08-17 |
| AU687602B2 (en) | 1998-02-26 |
| EP0777683A1 (de) | 1997-06-11 |
| CA2194999A1 (en) | 1996-02-08 |
| US5861375A (en) | 1999-01-19 |
| EP0777683A4 (de) | 1997-08-27 |
| AU3200495A (en) | 1996-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9603251D0 (en) | Lactobacillus strains of human origin, their compositions and uses thereof | |
| PL341364A1 (en) | 4-hydroxyqinoline-3-carboxamides and hydrazides as antiviral agents | |
| NO982310L (no) | Protegriner | |
| GB2288732B (en) | Pharmaceutical compositions | |
| GR3023233T3 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
| DE69830751D1 (de) | Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen | |
| ZA954679B (en) | Bicyclic compounds | |
| MY134806A (en) | Cyclosporins | |
| ES2182837T3 (es) | Piran-2-onas y 5,6-dihidropiran-2-onas utiles en el tratamiento del sida y de otros retrovirus. | |
| ZA943744B (en) | Therapeutic substituted guanidines | |
| EP0813544A4 (de) | ||
| AU1798995A (en) | Use of extracts of filamentous bacteria as cosmetic agents to combat ageing of the skin | |
| MXPA94009086A (es) | Guanidinas sustituidas terapeuticas. | |
| CY2183B1 (en) | Antiprotozoal cyclic tetrapeptides | |
| PL316656A1 (en) | Free halophantrin base for use in treating marsh-fever and compositions containing same | |
| GB9425730D0 (en) | Compounds | |
| BG102667A (en) | Diosgenine-containing composition | |
| IL104323A0 (en) | Hemoregulatory peptides | |
| GR3001850T3 (en) | Expellants of phytopathogenic microbes | |
| IL124354A0 (en) | Hemoregulatory compounds | |
| EP0663211A4 (de) | Mittel zur verhütung und behandlung von krankheiten der schleimhäute des verdauungstraktes. | |
| UA32146A (uk) | Спосіб оцінки ефективності лікування пародонтита | |
| UA32314A (uk) | Спосіб лікування некротичного панкреатиту |